TrialDrug design, development and therapy2019

Increased branching and sialylation of N-linked glycans correlate with an improved pharmacokinetic profile for BAY 81-8973 compared with other full-length rFVIII products.

John M Teare et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.